Time to Market

Missing the market is to avoid maximising on your return on investment. One is simply saying ‘we have one too’, and for a new product to be late to market means that your R&D spend will not be recovered as promptly or as completely as it could have been if you launched at the optimum time.

Moving from development to production can be fraught with problems and you may find that up scaling of laboratory processes simply produces new problems, that validation of processes takes longer and runs into difficulties, and that consistent quality is elusive.
 
Attention will be needed for speed to market & sustained launch roll out, time to volume ramp up, the development of robust validated manufacturing processes (DQ/IQ/OQ/PQ) and effective & timely technology transfer. In addition to this you need to ensure device robustness & component compatibility to minimise risk of device failure in the field, confirming the development of quality & reliability assured products that have achieve successful regulatory approval such as FDA / MHRA / EMEA.

EmsPT solutions will assist in all of these stages by monitoring everything even in the build up to operational volume; systems provide insight which has frequently provided data that allows processes to be tuned earlier than normal. There is much to do in a focussed initiative to meet with the planned time for a market launch, and a late launch may render expensive promotion to be valueless.
 
When you are planning the introduction of a new product would it help if the whole development to production stage was backed by a system that would automatically care for some of the issues that can be encountered, and readily identify problems that need attention?